@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-GC4P0B1H-M
  skos:hiddenLabel "Isonex"@en, "Phthivazide"@en, "Phthivazid"@en, "Ftivazide"@en, "Isonicotinic Acid Vanillylidenehydrazide"@en, "Tubazide"@en ;
  mesh:allowableQualifier jvr:-XV06LPML-W, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-W6SQV79N-S, jvr:-T9HQD7ST-J, jvr:-HQRFT0C6-B, jvr:-NHL3D2X0-S, jvr:-THHNVC7V-3, jvr:-G4R176S9-J, jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-Q3979798-W, jvr:-WK5F724J-1, jvr:-NFTHND7Q-8, jvr:-SBNWSM1T-R, jvr:-NKM836P1-M, jvr:-NB0XHT3S-N, jvr:-CB30NGKB-3, jvr:-TJHVZCRZ-0, jvr:-M63HSDM7-1, jvr:-L6C0XPHT-4, jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q, jvr:-G30ZJ446-J, jvr:-H7K65Q8S-Z ;
  skos:altLabel "149-17-7"@fr, "149-17-7"@en, "40Q4C3O4V0"@fr, "40Q4C3O4V0"@en, "4-Pyridinecarboxylic acid, hydrazide"@fr, "4-Pyridinecarboxylic acid, hydrazide"@en, "54-85-3 (Isoniazid)"@fr, "54-85-3 (Isoniazid)"@en, "Isonicotinic Acid Hydrazide"@en, "V83O1VOZ8L"@fr, "V83O1VOZ8L"@en ;
  skos:prefLabel "Isoniazid"@en, "Isoniazide"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D007538> ;
  a mesh:Descriptor, skos:Concept ;
  dc:modified "2016-05-31"^^xsd:date ;
  dc:established "1960-01-01"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-GZ0SG9R3-W, jvr:-NCM534SW-2 ;
  skos:definition "Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis."@en ;
  skos:broader jvr:-SZ501DJ2-2, jvr:-STBV9960-M ;
  skos:inScheme jvr: ;
  dc:created "1999-01-01"^^xsd:date .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SZ501DJ2-2
  skos:prefLabel "Isonicotinic Acids"@en, "Acides isonicotiniques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-GC4P0B1H-M .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-STBV9960-M
  skos:prefLabel "Hydrazines"@en, "Hydrazines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-GC4P0B1H-M .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-GZ0SG9R3-W
  skos:prefLabel "Fatty Acid Synthesis Inhibitors"@en, "Inhibiteurs de la synthèse d'acides gras"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NCM534SW-2
  skos:prefLabel "Antitubercular Agents"@en, "Antituberculeux"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .